Formulation development of buoyant controlled release tablets containing chitosan: Optimization of invitro dissolution and release kinetics

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 3, Issue SUPPL. 2, 2011, Pages 81-85

  Sahu, Atul Kumar ^a   Singh, Shailendra Kumar ^b   Verma, Amita ^c  

^a MLN MEDICAL COLLEGE   (India)

^b GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

^c SAM HIGGINBOTTOM UNIVERSITY OF AGRICULTURE   (India)

Author keywords

Chitosan; Floating drug delivery system; Gastroretentive; HPMC; Release kinetics

Indexed keywords

CHITOSAN; EXCIPIENT; FUROSEMIDE;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG SOLUBILITY; FACTORIAL ANALYSIS; FLOW KINETICS; IN VITRO STUDY; PHYSICAL CHEMISTRY; PROCESS OPTIMIZATION; TABLET FORMULATION;

EID: 84855437466     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Garg S, Sharma S. Gastroretentive Drug Delivery Systems. Pharm Tech 2003;13 Suppl 1:160-166.
2. Chungi VS, Ditter LW, Randal BS. Gastrointestinal sites of furosemide absorption in rats. Int J Pharm 1979;4: 27-38.
3. Ritschel WA. Targeting in the gastrointestinal tract: New approaches. Methods Find Exp Clin Pharmacol 1991;13: 313-336.
4. Menon A, Ritschel WA, Sakr A. Development and evaluation of a monolithic floating dosage form for furosemide. J Pharm Sci 1994; 83 suppl 2:239-245.
5. Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123-133.
6. Lin CC, Metters AT. Hydrogels in controlled release formulations: Network design and mathematical modeling. Adv Drug Del Rev 2006;58:1379-1408.
7. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Del Rev 2001;48:139-157.
8. Niebergall PJ, Milosovich G, Goyan, JE. Dissolution rate studies. II. Dissolution of particles under conditions of rapid agitation. J Pharm Sci 1963;52:236-241.
9. Prista, LN, Alves AC, Morgado RM. Técnica Farmacêutica e Farmácia Galénica, Vol. I. 5th ed. Fundaçâo Calouste Gulben kian: Lisboa; 1995. p. 453-454.
10. Moore JW, Flanner HH. Mathematical comparison of curves with an emphasis on in vitro dissolution profiles. Pharm Tech 1996;20:64-74.
11. Sharma N, Sharma A, Kohli K, Arora S. Development and evaluation of release equivalent sustained release formulation of dextromethorphan HBR using simple technology. Int J Pharm & Pharm Sci 2009; 1 suppl 1:121-127.
12. Dave BS, Amin AF, Patel MM. Gastroretentive Drug Delivery System of Ranitidine Hydrochloride: Formulation and In Vitro Evaluation. AAPS Pharm Sci Tech 2004; 5 suppl 2:1-6.
13. Mi FL, Her NL, Kuan CY, Wong TB, Shyu SS. Chitosan tablets for controlled release of theophylline - effect of polymer-drug wet or dry blending and anionic-cationic interpolymer complex. J Appl Polym Sci 1997;66:2495-2505.
14. Ritger PL, Peppas NA. A simple equation for description of solute release. II: Fickian and anomalous release from swellable devices. J Cont Release 1987b;5:37-42.
15. Hopfenberg HB, Hsu KC. Swelling-controlled, constant rate delivery systems. Polym Eng Sci 1978;18:1186-1191.
16. Peppas NA, Sahlin JJ. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int J Pharm 1989;57:169-172.
17. Krogel I, Bodmeier R. Floating or pulsatile drug delivery systems based on coated effervescent cores. Int J Pharm 1999;187:175-184.
18. Inouye K, Machida Y, Sannan T, Nagai T. Buoyant sustained release tablets based on Chitosan. Drug Des Del 1988;2:165-175.
19. Rubinstein A, Friend DR. Specific delivery to the gastrointestinal tract. In: Domb AJ, editors. Polymeric site specific pharmacotherapy. Wiley: Chichester; 1994. p. 282-283.
20. Streubel A, Siepmann J, Bodmeier R. Floating matrix tablets based on low density foam powder: effect of formulation and processing parameters on drug release. Eur J Pharm Sci 2003;18:37-45.
21. Dow Chemical Co. Methocel: Cellulose Ethers Technical Handbook San Diego, CA, USA: Dow Chemical Co; 1996. p. 18-20.
22. Wan LS, Heng PW, Wong LF. Matrix swelling kinetic model describing extent of swelling of HPMC matrices. Int J Pharm 1995;116:159-168.
23. Dortunc B, Gunal N. Release of acetazolamide from swellable hydroxypropyl methyl cellulose matrix tablets. Drug Dev Ind Pharm 1997;23:1245-1249.
24. Berger J, Reist M, Mayer JM, Felt O, Peppas NA, Gurny C. Structure and interaction in covalently and ionically crosslinked chitosan hydrogels for biomedical application. Eur J Pharm 2004;57:19-34.
25. Kawashima Y, Lin SY, Kasai A, Handa T, Takenaka H. Preparation of a prolonged release tablet of aspirin with chitosan. Chem Pharm Bull 1985;33:2107-2113.
26. Akbuga J. The effect of the physicochemical properties of a drug on its release from chitosonium malate matrix tablets. Int J Pharm 1993b;100:257-261.
27. Henriksen I, Skaugrud O, Karlsen J. Use of chitosan malate as an excipient in wet granulation of three water soluble drugs. Int J Pharm 1993;98:181-188.
28. Feely LC, Davis SS. Influence of surfactants on drug release from hydroxypropylmethylcellulose matrices. Int J Pharm 1988;41:83-89.
29. Ford JL, Rubinstein MH, Hogan JE. Formulation of sustained release promethazine hydrochloride tablets using hydroxypropylmethylcellulose matrices. Int J Pharm 1985;24:327-338.
30. Krogel I, Bodmeier R. Development of multifunctional matrix drug delivery system by an impermeable cylinder. J Cont Rel 1999a;61:43-50.
31. Wan LS, Heng PW, Wong LF. Matrix swelling kinetic model describing extent of swelling of HPMC matrices. Int J Pharm 1995;116:159-168.
32. Xu G, Groves MJ. Effect of FITC-dextran molecular weight on its release from floating cetyl alcohol and HPMC tablets. J Pharm Pharmacol 2001;53:49-56.